(CIDRAP News) The National Institutes of Health (NIH) yesterday announced it has awarded contracts, which could total $150 million over 5 years, to four companies to develop broad-spectrum therapies that could help the nation respond to a bioterror attack or other public health emergency.
(CIDRAP News) US government laboratories had 395 incidents that involved the potential release of select agents between 2003 and 2009, though only seven related infections were reported, according to a new National Research Council (NRC) report.
Sep 7, 2011
(CIDRAP News) A federal advisory committee is recommending that 11 bacterial species and viruses on the current "select agent" list, including anthrax and Ebola virus, be singled out for special safeguards and that another 19 agents be dropped from the list entirely.
(CIDRAP News) A report from the National Research Council (NRC) calls for some changes in a US Army immunization program for lab researchers who work with dangerous pathogens, saying the vaccines need to be made more accessible to civilian scientists.
(CIDRAP News) The National Research Council (NRC), in a letter report, has advised the US Army to prepare a more comprehensive risk assessment than it initially proposed for a biodefense laboratory to be built at Ft. Detrick in Frederick, Md.
Sep 21, 2010
(CIDRAP News) The US Department of Health and Human Services (HHS) has awarded a contract to a San Francisco company to further the development of a new broad-spectrum antibiotic for treating plague, tularemia, and various resistant infections.
May 27, 2010